Author: Fisher A.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.6, Iss.10, 1997-10, pp. : 1395-1412
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Muscarinic M1 agonists in the treatment of Alzheimer’s disease
By Korczyn A.D.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. :
Muscarinic Receptor Agonists in Alzheimer's Disease: More Than Just Symptomatic Treatment?
By Fisher A.
CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. :
By Messer W.S. Rajeswaran W.G. Cao Y. Zhang H.-J. El-Assadi A.A. Dockery C. Liske J. O'Brien J. Williams F.E. Huang X.-P. Wroblewski M.E. Nagy P.I. Peseckis S.M.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :